PURPOSE: The purpose of this study is to compare self-reported quality of life (QOL) scores in old and young patients with metastatic cancer using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C15-PAL questionnaire. MATERIALS AND METHODS: Patients receiving palliative radiotherapy (RT) for bone metastases and brain metastases completed the QLQ-C15-PAL questionnaire prior to treatment. Using multiple linear regression analysis, a parametric test, the QLQ-C15-PAL scores were compared using 65 and 70 years as cutoff ages. RESULTS: A total of 340 patients were referred for palliative RT for bone metastases (n = 190) or brain metastases (n = 150). Physical functioning and appetite were worse in the older group using either 65 or 70 years as the cutoff age. Age-related differences in the QLQ-C15-PAL scores varied as a function of age cutoff used and location of metastatic site irradiated. CONCLUSION: Based on the (EORTC) QLQ-C15-PAL, elderly advanced cancer patients have a different QOL profile. Similar observations have been reported with the (EORTC) QLQ-C30 questionnaire.
PURPOSE: The purpose of this study is to compare self-reported quality of life (QOL) scores in old and young patients with metastatic cancer using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C15-PAL questionnaire. MATERIALS AND METHODS:Patients receiving palliative radiotherapy (RT) for bone metastases and brain metastases completed the QLQ-C15-PAL questionnaire prior to treatment. Using multiple linear regression analysis, a parametric test, the QLQ-C15-PAL scores were compared using 65 and 70 years as cutoff ages. RESULTS: A total of 340 patients were referred for palliative RT for bone metastases (n = 190) or brain metastases (n = 150). Physical functioning and appetite were worse in the older group using either 65 or 70 years as the cutoff age. Age-related differences in the QLQ-C15-PAL scores varied as a function of age cutoff used and location of metastatic site irradiated. CONCLUSION: Based on the (EORTC) QLQ-C15-PAL, elderly advanced cancerpatients have a different QOL profile. Similar observations have been reported with the (EORTC) QLQ-C30 questionnaire.
Authors: Camilla Zimmermann; Debika Burman; Nadia Swami; Monika K Krzyzanowska; Natasha Leighl; Malcolm Moore; Gary Rodin; Ian Tannock Journal: Support Care Cancer Date: 2010-03-30 Impact factor: 3.603
Authors: Mogens Groenvold; Morten Aa Petersen; Neil K Aaronson; Juan I Arraras; Jane M Blazeby; Andrew Bottomley; Peter M Fayers; Alexander de Graeff; Eva Hammerlid; Stein Kaasa; Mirjam A G Sprangers; Jakob B Bjorner Journal: Eur J Cancer Date: 2005-09-12 Impact factor: 9.162
Authors: Se-Hyuk Kim; Robert J Weil; Samuel T Chao; Steven A Toms; Lilyana Angelov; Michael A Vogelbaum; John H Suh; Gene H Barnett Journal: Cancer Date: 2008-08-15 Impact factor: 6.860
Authors: Neil W Scott; Peter M Fayers; Neil K Aaronson; Andrew Bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten A Petersen; Mirjam A G Sprangers Journal: Qual Life Res Date: 2009-02-27 Impact factor: 4.147
Authors: Erin E Kent; Anita Ambs; Sandra A Mitchell; Steven B Clauser; Ashley Wilder Smith; Ron D Hays Journal: Cancer Date: 2014-11-04 Impact factor: 6.860
Authors: Juan Ignacio Arraras; Fernando Arias de la Vega; Gemma Asin; Mikel Rico; Uxue Zarandona; Clara Eito; Koldo Cambra; Marta Barrondo; Marta Errasti; Juan Verdún; Jose Rivadeneira; Miguel Angel Dominguez Journal: Qual Life Res Date: 2013-09-04 Impact factor: 4.147
Authors: Megan M Chock; Maria I Lapid; Pamela J Atherton; Simon Kung; Jeff A Sloan; Jarrett W Richardson; Matthew M Clark; Teresa A Rummans Journal: Int Psychogeriatr Date: 2013-09-04 Impact factor: 3.878
Authors: Varun Shahi; Maria I Lapid; Simon Kung; Pamela J Atherton; Jeff A Sloan; Matthew M Clark; Teresa A Rummans Journal: J Geriatr Oncol Date: 2014-04-14 Impact factor: 3.599